[ad_1] STOCKHOLM, Nov. 5, 2025 /PRNewswire/ — Moberg Pharma AB (publ) has entered into an exclusive licensing agreement with Karo Healthcare AB regarding the commercialization of MOB-015 (Terclara®) in Europe. The agreement comprises 19 European […]
Tag: Moberg Pharma
Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients
[ad_1] STOCKHOLM, Sept. 13, 2024 /PRNewswire/ — Moberg Pharma AB (OMX: MOB) announces that the company has received information about clinical cure in a subset of patients in the ongoing North American Phase 3 study for […]
